Sfoglia per Autore
Determinants of vitamin D activation in patients with acute coronary syndromes and its correlation with inflammatory markers
2021-01-01 Saghir Afifeh, A. M.; Verdoia, M.; Nardin, M.; Negro, F.; Viglione, F.; Rolla, R.; De Luca, G.
Use of Metformin and Platelet Reactivity in Diabetic Patients Treated with Dual Antiplatelet Therapy
2021-01-01 Verdoia, Monica; Pergolini, Patrizia; Rolla, Roberta; Ceccon, Claudia; Caputo, Marina; Aimaretti, Gianluca; Suryapranata, Harry; De Luca, Giuseppe
Association of lower vitamin D levels with inflammation and leucocytes parameters in patients with and without diabetes mellitus undergoing coronary angiography
2021-01-01 Verdoia, M.; Nardin, M.; Rolla, R.; Negro, F.; Gioscia, R.; Afifeh, A. M. S.; Viglione, F.; Suryapranata, H.; Marcolongo, M.; De Luca, G.
Impact of renin angiotensin system inhibitors on homocysteine levels and platelets reactivity in patients on dual antiplatelet therapy
2021-01-01 Nardin, M.; Verdoia, M.; Gioscia, R.; Negro, F.; De Luca, G.
Ticagrelor as compared to conventional antiplatelet agents in coronary artery disease: A comprehensive meta-analysis of 15 randomized trials
2021-01-01 Verdoia, M.; Savonitto, S.; Dudek, D.; Kedhi, E.; De Luca, G.
Vitamin D deficiency is associated with impaired reperfusion in STEMI patients undergoing primary percutaneous coronary intervention
2021-01-01 Verdoia, M.; Viglione, F.; Boggio, A.; Stefani, D.; Panarotto, N.; Malabaila, A.; Rolla, R.; Solda, P. L.; De Luca, G.
Low hemoglobin predicts high-platelet reactivity and major cardiovascular ischemic events at long-term follow-up among ACS patients receiving dual antiplatelet therapy with ticagrelor
2021-01-01 Verdoia, M.; Rolla, R.; Pergolini, P.; Gioscia, R.; Nardin, M.; Negro, F.; Viglione, F.; Suryapranata, H.; Kedhi, E.; De Luca, G.
Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registry
2021-01-01 Ciliberti, G.; Verdoia, M.; Merlo, M.; Zilio, F.; Vatrano, M.; Bianco, F.; Mancone, M.; Zaffalon, D.; Bonci, A.; Boscutti, A.; Infusino, F.; Coiro, S.; Stronati, G.; Tritto, I.; Gioscia, R.; Dello Russo, A.; Fedele, F.; Gallina, S.; Cassadonte, F.; Ambrosio, G.; Bonmassari, R.; De Luca, G.; Sinagra, G.; Capucci, A.; Kaski, J. C.; Guerra, F.
Comments on “Sex differences in distribution, management and outcomes of combined ischemic bleeding risk following acute coronary syndrome”
2021-01-01 Verdoia, M.; De Luca, G.
Impact of uric acid on immature platelet fraction in patients undergoing percutaneous coronary intervention
2021-01-01 Nardin, M.; Verdoia, M.; Negro, F.; Tonon, F.; De Luca, G.
Bleeding risk prediction in elderly patients managed invasively for acute coronary syndromes: External validation of the PRECISE-DAPT and PARIS scores
2021-01-01 Montalto, C.; Crimi, G.; Morici, N.; Piatti, L.; Grosseto, D.; Sganzerla, P.; Tortorella, G.; De Rosa, R.; De Luca, L.; De Luca, G.; Palmerini, T.; Valgimigli, M.; Savonitto, S.; De Servi, S.
Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial
2021-01-01 Kedhi, E.; Verdoia, M.; Suryapranata, H.; Damen, S.; Camaro, C.; Benit, E.; Barbieri, L.; Rasoul, S.; Liew, H. B.; Polad, J.; Ahmad, W. A.; Zambahari, R.; Lalmand, J.; van der Schaaf, R. J.; Koh, T. H.; Timmermans, P.; Dilling-Boer, D.; Veenstra, L. F.; van' t Hof, A. W.; Lee, S. W.; Roolvink, V.; Ligtenberg, E.; Postma, S.; Kolkman, E. J.; Brouwer, M. A.; Dudek, D.; De Luca, G.
Impact of Age on the Functional Evaluation of Intermediate Coronary Stenoses With Instantaneous Wave-Free Ratio and Fractional Flow Reserve
2021-01-01 Verdoia, M.; Gioscia, R.; Nardin, M.; Negro, F.; Tonon, F.; Suryapranata, H.; Khedi, E.; Marcolongo, M.; De Luca, G.
Impact of the polymorphism RS5751876 of the purinergic receptor ADORA2A on periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention
2021-01-01 Negro, F.; Verdoia, M.; Nardin, M.; Suryapranata, H.; Kedhi, E.; Dudek, D.; De Luca, G.
Prognostic impact of Vitamin D deficiency in patients with coronary artery disease undergoing percutaneous coronary intervention
2021-01-01 Verdoia, M.; Nardin, M.; Rolla, R.; Negro, F.; Gioscia, R.; Afifeh, A. M. S.; Viglione, F.; Suryapranata, H.; Marcolongo, M.; De Luca, G.
Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients
2021-01-01 Silverio, A.; Di Maio, M.; Citro, R.; Esposito, L.; Iuliano, G.; Bellino, M.; Baldi, C.; De Luca, G.; Ciccarelli, M.; Vecchione, C.; Galasso, G.
Cholecalciferol levels, inflammation and leukocytes parameters: Results from a large single-centre cohort of patients
2021-01-01 Verdoia, M.; Nardin, M.; Rolla, R.; Negro, F.; Gioscia, R.; Saghir Afifeh, A. M.; Viglione, F.; Suryapranata, H.; Marcolongo, M.; De Luca, G.
Preprocedural β-Blockers in the Functional Assessment of Intermediate Coronary Lesions by Instantaneous Wave-Free Ratio
2021-01-01 Verdoia, M.; Gioscia, R.; Nardin, M.; Viola, O.; Brancati, M. F.; Solda, P. L.; Marcolongo, M.; De Luca, G.
Association between vitamin D deficiency and serum Homocysteine levels and its relationship with coronary artery disease
2021-01-01 Verdoia, M.; Nardin, M.; Gioscia, R.; Saghir Afifeh, A. M.; Viglione, F.; Negro, F.; Marcolongo, M.; De Luca, G.
Relationship between adenosine A2a receptor polymorphism rs5751876 and fractional flow reserve during percutaneous coronary intervention
2020-01-01 Nardin, M.; Verdoia, M.; Negro, F.; Suryapranata, H.; Khedi, E.; De Luca, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Determinants of vitamin D activation in patients with acute coronary syndromes and its correlation with inflammatory markers | 1-gen-2021 | Saghir Afifeh, A. M.; Verdoia, M.; Nardin, M.; Negro, F.; Viglione, F.; Rolla, R.; De Luca, G. | |
| Use of Metformin and Platelet Reactivity in Diabetic Patients Treated with Dual Antiplatelet Therapy | 1-gen-2021 | Verdoia, Monica; Pergolini, Patrizia; Rolla, Roberta; Ceccon, Claudia; Caputo, Marina; Aimaretti, Gianluca; Suryapranata, Harry; De Luca, Giuseppe | |
| Association of lower vitamin D levels with inflammation and leucocytes parameters in patients with and without diabetes mellitus undergoing coronary angiography | 1-gen-2021 | Verdoia, M.; Nardin, M.; Rolla, R.; Negro, F.; Gioscia, R.; Afifeh, A. M. S.; Viglione, F.; Suryapranata, H.; Marcolongo, M.; De Luca, G. | |
| Impact of renin angiotensin system inhibitors on homocysteine levels and platelets reactivity in patients on dual antiplatelet therapy | 1-gen-2021 | Nardin, M.; Verdoia, M.; Gioscia, R.; Negro, F.; De Luca, G. | |
| Ticagrelor as compared to conventional antiplatelet agents in coronary artery disease: A comprehensive meta-analysis of 15 randomized trials | 1-gen-2021 | Verdoia, M.; Savonitto, S.; Dudek, D.; Kedhi, E.; De Luca, G. | |
| Vitamin D deficiency is associated with impaired reperfusion in STEMI patients undergoing primary percutaneous coronary intervention | 1-gen-2021 | Verdoia, M.; Viglione, F.; Boggio, A.; Stefani, D.; Panarotto, N.; Malabaila, A.; Rolla, R.; Solda, P. L.; De Luca, G. | |
| Low hemoglobin predicts high-platelet reactivity and major cardiovascular ischemic events at long-term follow-up among ACS patients receiving dual antiplatelet therapy with ticagrelor | 1-gen-2021 | Verdoia, M.; Rolla, R.; Pergolini, P.; Gioscia, R.; Nardin, M.; Negro, F.; Viglione, F.; Suryapranata, H.; Kedhi, E.; De Luca, G. | |
| Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registry | 1-gen-2021 | Ciliberti, G.; Verdoia, M.; Merlo, M.; Zilio, F.; Vatrano, M.; Bianco, F.; Mancone, M.; Zaffalon, D.; Bonci, A.; Boscutti, A.; Infusino, F.; Coiro, S.; Stronati, G.; Tritto, I.; Gioscia, R.; Dello Russo, A.; Fedele, F.; Gallina, S.; Cassadonte, F.; Ambrosio, G.; Bonmassari, R.; De Luca, G.; Sinagra, G.; Capucci, A.; Kaski, J. C.; Guerra, F. | |
| Comments on “Sex differences in distribution, management and outcomes of combined ischemic bleeding risk following acute coronary syndrome” | 1-gen-2021 | Verdoia, M.; De Luca, G. | |
| Impact of uric acid on immature platelet fraction in patients undergoing percutaneous coronary intervention | 1-gen-2021 | Nardin, M.; Verdoia, M.; Negro, F.; Tonon, F.; De Luca, G. | |
| Bleeding risk prediction in elderly patients managed invasively for acute coronary syndromes: External validation of the PRECISE-DAPT and PARIS scores | 1-gen-2021 | Montalto, C.; Crimi, G.; Morici, N.; Piatti, L.; Grosseto, D.; Sganzerla, P.; Tortorella, G.; De Rosa, R.; De Luca, L.; De Luca, G.; Palmerini, T.; Valgimigli, M.; Savonitto, S.; De Servi, S. | |
| Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial | 1-gen-2021 | Kedhi, E.; Verdoia, M.; Suryapranata, H.; Damen, S.; Camaro, C.; Benit, E.; Barbieri, L.; Rasoul, S.; Liew, H. B.; Polad, J.; Ahmad, W. A.; Zambahari, R.; Lalmand, J.; van der Schaaf, R. J.; Koh, T. H.; Timmermans, P.; Dilling-Boer, D.; Veenstra, L. F.; van' t Hof, A. W.; Lee, S. W.; Roolvink, V.; Ligtenberg, E.; Postma, S.; Kolkman, E. J.; Brouwer, M. A.; Dudek, D.; De Luca, G. | |
| Impact of Age on the Functional Evaluation of Intermediate Coronary Stenoses With Instantaneous Wave-Free Ratio and Fractional Flow Reserve | 1-gen-2021 | Verdoia, M.; Gioscia, R.; Nardin, M.; Negro, F.; Tonon, F.; Suryapranata, H.; Khedi, E.; Marcolongo, M.; De Luca, G. | |
| Impact of the polymorphism RS5751876 of the purinergic receptor ADORA2A on periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention | 1-gen-2021 | Negro, F.; Verdoia, M.; Nardin, M.; Suryapranata, H.; Kedhi, E.; Dudek, D.; De Luca, G. | |
| Prognostic impact of Vitamin D deficiency in patients with coronary artery disease undergoing percutaneous coronary intervention | 1-gen-2021 | Verdoia, M.; Nardin, M.; Rolla, R.; Negro, F.; Gioscia, R.; Afifeh, A. M. S.; Viglione, F.; Suryapranata, H.; Marcolongo, M.; De Luca, G. | |
| Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients | 1-gen-2021 | Silverio, A.; Di Maio, M.; Citro, R.; Esposito, L.; Iuliano, G.; Bellino, M.; Baldi, C.; De Luca, G.; Ciccarelli, M.; Vecchione, C.; Galasso, G. | |
| Cholecalciferol levels, inflammation and leukocytes parameters: Results from a large single-centre cohort of patients | 1-gen-2021 | Verdoia, M.; Nardin, M.; Rolla, R.; Negro, F.; Gioscia, R.; Saghir Afifeh, A. M.; Viglione, F.; Suryapranata, H.; Marcolongo, M.; De Luca, G. | |
| Preprocedural β-Blockers in the Functional Assessment of Intermediate Coronary Lesions by Instantaneous Wave-Free Ratio | 1-gen-2021 | Verdoia, M.; Gioscia, R.; Nardin, M.; Viola, O.; Brancati, M. F.; Solda, P. L.; Marcolongo, M.; De Luca, G. | |
| Association between vitamin D deficiency and serum Homocysteine levels and its relationship with coronary artery disease | 1-gen-2021 | Verdoia, M.; Nardin, M.; Gioscia, R.; Saghir Afifeh, A. M.; Viglione, F.; Negro, F.; Marcolongo, M.; De Luca, G. | |
| Relationship between adenosine A2a receptor polymorphism rs5751876 and fractional flow reserve during percutaneous coronary intervention | 1-gen-2020 | Nardin, M.; Verdoia, M.; Negro, F.; Suryapranata, H.; Khedi, E.; De Luca, G. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile